Jones Gregory D, Caso Raul, No Jae Seong, Tan Kay See, Dycoco Joseph, Bains Manjit S, Rusch Valerie W, Huang James, Isbell James M, Molena Daniela, Park Bernard J, Jones David R, Rocco Gaetano
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Weill Cornell Medical College, New York, NY, USA.
Eur J Cardiothorac Surg. 2020 Jul 1;58(1):78-85. doi: 10.1093/ejcts/ezaa027.
Locally advanced non-small-cell lung cancer (NSCLC) with chest wall invasion carries a high risk of recurrence and portends poor survival (30-40% and 20-50%, respectively). No studies have identified prognostic factors in patients who underwent R0 resection for non-superior sulcus NSCLC.
A retrospective review was conducted for all chest wall resections for NSCLC from 2004 to 2018. Patients with superior sulcus tumours, partial (<1 rib) or incomplete (R1/R2) resection or distant metastasis were excluded. Disease-free survival (DFS) and overall survival (OS) were estimated using the Kaplan-Meier method. Cox proportional hazards modelling was used to determine factors associated with DFS and OS.
A total of 100 patients met inclusion criteria. Seventy-three (73%) patients underwent induction therapy, and all but 12 (16%) patients experienced a partial radiological response. A median of 3 ribs was resected (range 1-7), and 67 (67%) patients underwent chest wall reconstruction. The 5-year DFS and OS were 36% and 45%, respectively. Pathological N2 status [hazard ratio (HR) 3.12, confidence interval (CI) 1.56-6.25; P = 0.001], intraoperative blood transfusion (HR 2.24, CI 1.28-3.92; P = 0.005) and preoperative forced vital capacity (per % forced vital capacity, HR 0.97, CI 0.96-0.99; P = 0.013) were associated with DFS. Increasing pathological stage, lack of radiological response to induction therapy (HR 7.35, CI 2.35-22.99; P = 0.001) and cardiovascular comorbidity (HR 2.43, CI 1.36-4.36; P = 0.003) were associated with OS.
We demonstrate that blood transfusion and forced vital capacity are associated with DFS after R0 resection for non-superior sulcus NSCLC, while radiological response to induction therapy greatly influences OS. We confirm that pathological nodal status and pathological stage are reproducible determinants of DFS and OS, respectively.
局部晚期非小细胞肺癌(NSCLC)侵犯胸壁时复发风险高,预后较差(分别为30 - 40%和20 - 50%)。尚无研究确定非肺上沟NSCLC行R0切除患者的预后因素。
对2004年至2018年所有因NSCLC行胸壁切除的患者进行回顾性分析。排除肺上沟肿瘤、部分(<1根肋骨)或不完全(R1/R2)切除或远处转移的患者。采用Kaplan-Meier法估计无病生存期(DFS)和总生存期(OS)。使用Cox比例风险模型确定与DFS和OS相关的因素。
共有100例患者符合纳入标准。73例(73%)患者接受了诱导治疗,除12例(16%)外,所有患者均有部分影像学缓解。平均切除3根肋骨(范围1 - 7),67例(67%)患者接受了胸壁重建。5年DFS和OS分别为36%和45%。病理N2状态[风险比(HR)3.12,置信区间(CI)1.56 - 6.25;P = 0.001]、术中输血(HR 2.24,CI 1.28 - 3.92;P = 0.005)和术前用力肺活量(每%用力肺活量,HR 0.97,CI 0.96 - 0.99;P = 0.013)与DFS相关。病理分期增加、诱导治疗无影像学缓解(HR 7.35,CI 2.3